T2D.com Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 5.4/10
Best for: a published list of the one state it serves, when most sellers publish none
T2D.com falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked July 2026
T2D.com bundles the prescriber, the medication, and home delivery into one service covering compounded semaglutide and tirzepatide. It is a subsidiary of Vertical Insight Corp, and the program is built specifically for people managing type 2 diabetes and pre-diabetes.
Is T2D.com legit?
Yes. T2D.com is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 5.4/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a T2D.com promo or coupon code?
We know of no promo or coupon code for T2D.com. Its listed price is $999 a month. Coupon sites advertising "T2D.com discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how T2D.com compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to T2D.com
Editorial score · methodology
Editorial score · methodology
Embody
Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Editorial score · methodology
T2D.com at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $999/mo
- What's included
- Medication · Consult · Shipping
- Availability
- 1 states
- FDA status
- No FDA warning letters found
How T2D.com scores
Six columns, each one computed from something T2D.com has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
2.2/10Serves 1 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on T2D.com
Last checked July 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: 1 state
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for T2D.com
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with T2D.com involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1T2D.com shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask T2D.com which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- T2D.com serves 1 of 50 states, so check that yours is one of them.
GLP-1 medications T2D.com offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off T2D.com's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to T2D.com
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Serves only 1 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What T2D.com charges
T2D.com charges $999/month.
- Compounded semaglutide: $999/month
- Compounded tirzepatide: $999/month
MangoRx dispenses semaglutide and tirzepatide from $299/month, which makes it the fair comparison to run before you commit here.
What T2D.com dispenses
T2D.com prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
Safety and disclosure
T2D.com tells you the 1 states it serves. We found no FDA warning letters issued to T2D.com. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If T2D.com will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether T2D.com bills your plan before you start.
Our read
T2D.com charges $999/month. Too few sellers offer the same drug and form to say whether that is cheap or expensive, so judge it on what the package includes. The catch is disclosure, which is why T2D.com scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
T2D.com falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay T2D.com
Starting at $999 a month. Check today's price, then start the intake.
Where T2D.com is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare T2D.com head to head
The sellers closest to T2D.com on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this T2D.com review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of July 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See T2D.com's current pricing
Plans start at $999 a month. Whether you qualify is a clinician's decision, made after your intake.